Join me in ep 9 as I sit down with CEO of Oncode, Su Wen Lim. Su Wen shares several ways that precision medicine is changing cancer diagnosis & treatment; being at the forefronts of precision medicine in cancer diagnostics; and advice to aspiring scientists looking to make a change in healthcare.
(0:00) Introduction
(2:12) How precision medicine helps cancer diagnosis
(2:57) Early detection of relapses and cancers
(3:31) Oncode's unique propositions compared to other diagnostic solutions
(5:51) Gaining market access as one of the first precision medicine lab
(8:02) Raising funds as a female entrepreneur in healthcare
(10:14) Making precision medicine accessible
(13:39) Advice to aspiring scientists
Oncode is a precision medicine laboratory with a niche in cancer molecular diagnostics. They are the first precision medicine center in Malaysia, with full world-class facilities.
Su Wen Lim holds a PhD in BioSciences, Oncology and Cancer Biology, Molecular Biology, Cell Culture from the University of Nottingham. She holds experiences as a scientist in both commercial and academia settings, and is now the Founder & CEO of Oncode Scientific.
Subscribe now for more engaging discussions at the intersection of technology and healthcare. Stay curious, stay inspired, and delve into the world of #Medtech & #Biotech with us!
#precisionmedicine #precisiononcology #precisionmedicinecancer #Cancertreatment #deepmedtech #Medicalpodcast #Southeastasia #SEA #Medtechpodcast
